Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 144

1.
2.

Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia.

Sävman K, Heyes MP, Svedin P, Karlsson A.

Transl Stroke Res. 2013 Apr;4(2):228-35. doi: 10.1007/s12975-012-0216-3. Epub 2012 Oct 13.

3.

Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.

El-Khodor BF, Edgar N, Chen A, Winberg ML, Joyce C, Brunner D, Suárez-Fariñas M, Heyes MP.

Exp Neurol. 2008 Jul;212(1):29-43. doi: 10.1016/j.expneurol.2008.02.025. Epub 2008 Mar 18.

PMID:
18455159
5.

Cerebrospinal fluid and serum markers of inflammation in autism.

Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP.

Pediatr Neurol. 2005 Sep;33(3):195-201.

PMID:
16139734
6.
7.

Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy.

Eggers V, Fügener K, Hein OV, Rommelspacher H, Heyes MP, Kox WJ, Spies CD.

Intensive Care Med. 2004 Aug;30(8):1544-51. Epub 2004 Apr 27.

PMID:
15112034
8.

Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro.

Gunther EC, Stone DJ, Gerwien RW, Bento P, Heyes MP.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9608-13. Epub 2003 Jul 17.

9.

Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies.

Rider LG, Schiffenbauer AS, Zito M, Lim KL, Ahmed A, Zemel LS, Rennebohm RM, Passo MH, Summers RM, Hicks JE, Lachenbruch PA, Heyes MP, Miller FW; Juvenile Dermatomyositis Disease Activity Collaboration Study Group.

Clin Chem. 2002 Oct;48(10):1681-8.

10.

Cerebrospinal fluid glutamine, tryptophan, and tryptophan metabolite concentrations in dogs with portosystemic shunts.

Holt DE, Washabau RJ, Djali S, Dayrell-Hart B, Drobatz KJ, Heyes MP, Robinson MB.

Am J Vet Res. 2002 Aug;63(8):1167-71.

PMID:
12171172
12.

LC/MS analysis of NAD biosynthesis using stable isotope pyridine precursors.

Evans J, Wang TC, Heyes MP, Markey SP.

Anal Biochem. 2002 Jul 15;306(2):197-203.

PMID:
12123656
13.

Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages.

Jiang ZG, Piggee C, Heyes MP, Murphy C, Quearry B, Bauer M, Zheng J, Gendelman HE, Markey SP.

J Neuroimmunol. 2001 Jul 2;117(1-2):97-107.

PMID:
11431009
14.

Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.

Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, Archibald S, Jernigan TL; HNRC Group. HIV Neurobehavioral Research Center.

Brain. 2001 May;124(Pt 5):1033-42.

PMID:
11335705
15.
16.

Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.

Saito K, Fujigaki S, Heyes MP, Shibata K, Takemura M, Fujii H, Wada H, Noma A, Seishima M.

Am J Physiol Renal Physiol. 2000 Sep;279(3):F565-72.

17.
18.

U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression.

Chao CC, Hu S, Gekker G, Lokensgard JR, Heyes MP, Peterson PK.

Neuropharmacology. 2000;39(1):150-60.

PMID:
10665828
19.
20.

Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis.

Morrison PF, Morishige GM, Beagles KE, Heyes MP.

J Neurochem. 1999 May;72(5):2135-44.

Supplemental Content

Loading ...
Support Center